Good Day BIO Newsletter

The risk of forest fires is increasing—but biotech has solutions to put them out and even prevent them. For National Immunization Awareness Month, we have an exclusive interview with GSK’s Director of U.S. Vaccine Policy about how we can increase routine adult vaccination and access. (507 words, 2 minutes, 32 seconds)

Respiratory virus season is coming—but for the first year ever, we have protection against COVID-19, influenza, AND RSV. Plus, new market research highlights what’s needed to continue to grow the sustainable aviation fuel market. (494 words, 2 minutes, 28 seconds)

Two new reports show how the plant biostimulants market is growing—but it needs good policy to truly thrive. Plus, a recent Facebook Live featuring two BIO leaders explored how we can make clinical trials more diverse. (528 words, 2 minutes, 38 seconds)

New data uncovers the cause of last year’s measles outbreak among children in Ohio—plus, the latest news on the Farm Bill as the September deadline looms. (524 words, 2 minutes, 37 seconds)

A new study explores links between air pollution and premature deaths from antimicrobial resistance (AMR), and over the past month, extreme weather has devastated tomato crops in India. Biotech could provide solutions to both challenges. (586 words, 2 minutes, 55 seconds)

Today, we’re looking at a flurry of new approvals and announcements—signs of the potential of biotech to solve our greatest health challenges, if policy doesn’t thwart the progress. Plus, valley fever is looking bad in California—rain and a fungus are to blame. (507 words, 2 minutes, 32 seconds)

This week is off to a busy start, with the House introducing bills to strengthen the Vaccine Injury Compensation Program, Colorado’s PDAB taking action, and an important discussion on AMR and amputees. (834 words, 4 minutes, 10 seconds)

A busy news Friday: CDC advisors voted to recommend the routine use of the first approved monoclonal antibody for RSV in infants, and a new poll shows voters like agricultural biotech and want faster regulatory approvals. (528 words, 2 minutes, 38 seconds)

We have profiles of three cancer innovators—and why it matters in the context of recent policy developments. Plus, the Pantheon Awards are accepting nominations until August 11 and NIH announced Dr. Fauci’s successor. (476 words, 2 minutes, 22 seconds)

BIO recently submitted comments to the U.S. Senate on the 340B program—here’s what we said, plus a recap of a successful BIO Asia-Taiwan. (406 words, 2 minutes, 1 second)